This mimics the natural signaling pathway your body uses to regulate GH production
Standard Dosing Ranges The most extensively studied dosing protocols for subcutaneous administration include: Research-Based Dosing Protocols Beginner/Conservative Protocol: Dose: 250-300 mcg once daily Duration: 4-8 weeks initial assessment period Rationale: Allows tolerance assessment and response evaluation at lower end of therapeutic range Standard Protocol: Dose: 300-500 mcg once daily Duration: 12-24 weeks based on clinical trials Rationale: Most commonly studied range in human research with optimal benefit-to-safety ratio Advanced Protocol: Dose: 500 mcg-1 mg once daily Duration: 12-24 weeks under close medical monitoring Rationale: Upper clinical range
It effectively increases the "pool" of GH available for release
It improves how efficiently your body processes glucose after meals
Bergmann, University of Southern Denmark, Denmark Updates Copyright 2021 Fontova, Colom, Rigo-Bonnin, van Merendonk, Vidal-Alabr, Montero, Melilli, Meneghini, Manonelles, Cruzado, Torras, Griny, Bestard and Lloberas
What is CJC-1295/Ipamorelin Blend